SPVs Explained: The Single-Deal Vehicle That's Either Your Best Bet or a $250K Lottery Ticket

SPVs Explained: The Single-Deal Vehicle That's Either Your Best Bet or a $250K Lottery Ticket

An SPV costs $8,000 to set up on AngelList and lets you concentrate your entire allocation into one company. That's either surgical precision — or a coin flip with a $250,000 minimum buy-in. I've watched smart investors use SPVs brilliantly and I've watched smart investors use them to light money on fire. The difference wasn't luck. It was whether they understood what they were actually buying.

What the Marketing Doesn't Tell You

Every syndicate pitch deck says the same thing: "Exclusive access to the best deals." That framing is backward. The best deals go to the GP's fund first. The SPV gets what's left over — the allocation the fund couldn't absorb, or deals that don't fit the fund's thesis but happen to be easy to raise capital for.

That's not always bad. Overflow from a top-tier fund can still be excellent deal flow. But you need to know the GP well enough to verify which bucket you're in. Are you getting the deals they believe in most? Or the deals they needed to offload to justify the formation cost?

If you can't answer that question before you wire money, you're not investing — you're donating to a GP's carry stream.

SPV Meaning: The Mechanics Without the Jargon

A special purpose vehicle — SPV — is a Delaware LLC created for one purpose: to hold equity in a single company. The GP (the syndicate lead) forms the LLC, raises capital from limited partners like you, wires that capital to the startup, and holds the shares until exit. When the company goes public or gets acquired, the SPV distributes proceeds to LPs and dissolves.

You don't own shares in the startup directly. You own a piece of an LLC that owns shares in the startup. That extra legal layer matters — for taxes, for voting rights, and for what happens when the company raises a down round and you need someone defending your position.

The GP runs the whole show post-close. They decide whether to exercise pro-rata rights in follow-on rounds. They decide whether to sell on a secondary. They decide when and whether to call a liquidity event. You sign subscription documents once and then largely wait. That dynamic is fine when you trust the GP completely. It's a problem when you don't.

SPV formation counts have climbed 116% over five years (Carta, 2025). Falling setup costs drove most of that growth. What hasn't fallen is the risk.

What an SPV Investment Actually Costs

The $8,000 AngelList headline fee is real but incomplete. Here's what a $500,000 SPV across 20 investors actually costs you:

AngelList charges $8,000 setup plus a $2,000 blue sky filing fee — $10,000 before you've done anything. Then 0.15% of AUM annually. Then, critically, 5% platform carry on profits. On a $500K SPV that exits at 3x, that's $1 million in profit. AngelList takes $50,000 off the top. Your GP takes their own carry on top of that. The setup fee is the least of your costs.

Allocations charges $9,950 flat with zero platform carry. Higher upfront, cleaner backend — especially if your deal exits well. For active syndicate leads running five or more deals per year, that math compounds fast in your favor.

Sydecar charges 2% of capital raised, with a floor of $4,500 and a ceiling of $12,500. On a $250K SPV that's $5,000. On a $500K SPV that's $10,000 — same as AngelList before carry. Sydecar takes no platform carry and claims a one-week formation speed. That speed matters in competitive rounds where waiting two weeks means missing the deal entirely.

Below $250,000 in raise size, the fixed costs eat more than 10% of deployed capital before you've made a single investment decision. That's the floor where an SPV investment starts making economic sense. Below it, you're funding infrastructure, not companies.

The Tax Situation Nobody Explains Until It's Too Late

SPVs are pass-through entities. All income, gains, and losses flow to you on a Schedule K-1. That sounds fine until you've missed your April 15 deadline because the portfolio company is still closing its books in March.

Here's the dependency chain nobody draws in the pitch deck: The startup has to close its fiscal year. Then the SPV manager calculates each LP's pro-rata share of income and gains. Then K-1s get issued. Then you file. If the company has a foreign subsidiary, an ongoing audit, or a currency restatement — and plenty of Series B companies have all three — your K-1 arrives in April. Or May. You file an extension. You pay a penalty. Meanwhile you've been explaining this to your accountant since February.

Phantom income is worse. I've seen investors owe taxes on gains they haven't received in cash. SAFE note conversions can trigger taxable events. Convertible note interest accrues as income even though no cash changes hands. An LLC-to-C-Corp flip at the portfolio company can create a realized gain on paper with zero dollars distributed. You owe taxes now. You receive nothing. You cover the liability out of pocket and hope the actual exit arrives before you do it again next year.

State nexus adds another layer. If the portfolio company operates in California, New York, or Texas, the SPV may have filing obligations in those states. Non-resident LPs can end up owing state taxes on entities they'd never choose to be connected to. Larger SPVs above $2 million sometimes use corporate tax blockers to contain this, but that adds $6,000 to $12,000 to formation cost.

Budget for tax complexity as a line item before you commit capital. It's not a minor administrative inconvenience.

The GP Conflicts That Kill LP Returns

Deal warehousing is the cleanest structural conflict in syndicate investing. The GP uses personal capital to lock in an allocation before raising from LPs — that part is fine, often necessary in fast-moving rounds. The conflict is what happens next. The GP now holds multiple warehoused deals and decides which ones to syndicate. The best deals stay on the GP's own balance sheet. The good-but-not-great deals go to LPs. You see the pitch for the one they're syndicating, not the one they kept.

Ask every GP you're considering: Is this deal warehoused? What was your original cost basis? Transparent GPs answer in two sentences. Evasive GPs signal something worse than the answer would have.

Volume incentives create the second conflict. A syndicate GP earns carry deal by deal, not portfolio-wide. Run 10 SPVs, nine fail, one returns 10x — the GP earns carry on the winner. LPs, spread across all ten deals, lose money in aggregate. That math works fine for the GP. It's bad for you. Compare that to a traditional fund structure, where the GP earns zero carry unless the entire portfolio turns a profit. The incentive alignment is categorically different.

The third conflict is post-close disappearance. Once a GP has deployed your capital, their financial incentive to spend time on your SPV drops significantly. Pay-to-play rounds, down-round defense, pro-rata evaluation — these require attention. Tourist GPs don't provide it. If the company raises a pay-to-play Series B and your GP doesn't evaluate whether to participate, you could dilute from 1% to 0.3% permanently. That dilution won't show up in any headline return figure the GP publishes later.

When an SPV Makes Sense — and When It Doesn't

I've put capital into SPVs and I'd do it again under the right conditions. Here's what those conditions look like.

Say yes when the GP has real skin in the game — not $5,000 symbolic co-investment, but a meaningful personal check relative to the total raise. Say yes when the deal flow is verifiable, meaning you can trace the GP's track record across multiple deals and confirm it independently. Say yes when you can genuinely afford to lose every dollar in that specific vehicle without it changing your investment strategy for the next two years. And say yes when the GP's post-investment governance is explicit: who evaluates follow-ons, what's the timeline, how are secondary decisions made.

Walk away from first-time GPs who have never exited a company. Walk away when the GP has no co-investment or the co-investment is a token amount designed to check a box. Walk away when the SPV is being syndicated to more than 100 LPs — that's a fundraising machine, not a deal. At that LP count, the GP's job is raising capital, not managing your investment. Walk away when you can't verify the allocation is actually secured before committing.

The minimum viable SPV strategy — if you're building a genuine portfolio rather than making single bets — is $5 million or more deployed across ten or more deals. That's the threshold where diversification starts functioning. Below it, you own a lottery ticket with a carry structure attached.

Venture returns follow a power law. Most companies fail. A few drive all the returns. A single SPV has an 80% probability of returning zero, based on historical startup failure rates. A fund with 20 portfolio companies has near-certain odds of hitting at least one 10x and several 2-3x exits. If you have $100,000 to invest and you're choosing between one SPV and a diversified fund run by a proven manager, the fund wins on math alone. The SPV only wins if you have unique information about that specific deal — and that's a high bar to clear honestly.

Platform Comparison: Where Your Setup Dollar Goes

AngelList runs the largest SPV deal volume in the market — roughly $3 billion annually. The LP marketplace is a genuine advantage; you can raise from investors you've never met. The 5% platform carry is the real cost. It doesn't appear on the setup invoice, which is why many first-time GPs underestimate the total fee load on their LPs. AngelList is the right choice when you need the network and your deals are large enough to absorb the carry cost.

Allocations published their pricing: $9,950 for a standard SPV, zero platform carry. No hidden add-ons, no sales-quoted surprises. For GPs who source their own LPs and want clean, predictable economics, Allocations is the cleaner structure. LPs who've been burned by opaque fee schedules tend to prefer working with GPs on this platform.

Sydecar prices at 2% of capital with a $4,500 floor and $12,500 ceiling. Zero carry. One-week formation. For small to mid-size SPVs in the $100,000 to $500,000 range where speed matters, Sydecar hits the right cost-efficiency point. The surcharges for pass-through investments and non-US deals ($3,000 each) can add up on complex structures, so model the full cost before assuming the 2% headline.

Three Questions Before You Sign

Before you commit to any SPV, ask the GP these questions and pay attention to how quickly and clearly they answer.

First: What percentage of this SPV are you personally investing, and at what valuation? If the GP is warehousing shares at a discount and selling them to the SPV at a markup, you need to know. If they're not co-investing at all, you need to know that too.

Second: Walk me through your last three SPV exits — IRR, hold period, and whether you exercised pro-rata in any follow-on rounds. Portfolio-wide performance, not cherry-picked winners. If they can't answer this in ten minutes, they don't have three exits to walk you through.

Third: When this company raises its next round, who decides whether we participate, what's your process, and what does participation look like for LPs? The answer to this question tells you whether the GP is managing your investment or just closing it.

SPV investing can be excellent. Concentrated access to a single breakout company, deployed early, at the right price — that's a real outcome. But the vehicle doesn't generate returns. The deal does. The GP does. The platform is just where the paperwork lives.

Know what you're buying before you wire the money.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

This article is for informational and educational purposes only and does not constitute investment, legal, or tax advice. Always consult a qualified financial advisor, attorney, or tax professional before making investment decisions.